PRGO Q4 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+4.6% YoY

Gross Profit

$383M33.1% margin

Operating Income

$31M2.7% margin

Net Income

-$24M-2.1% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+5.0%

Cash Flow

Operating Cash Flow

$186M

Free Cash Flow

$160M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$6.2B

Stockholders' Equity

$4.8B

Cash & Equivalents

$601M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+4.6%
Gross Profit	$383M	$362M	+5.6%
Operating Income	$31M	$47M	-33.6%
Net Income	-$24M	$10M	-346.9%

Revenue Segments

Consumer Self-Care Americas

$766M66%

Consumer Self-Care International

$390M34%

Geographic Segments

UNITED STATES

$753M65%

Europe

$376M32%

Other Geographical Areas

$26M2%

IRELAND

$9M1%